Sinopharm Group Co Ltd
01099: XHKG (HKG)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| HKD 53.70 | Ljjnzh | Rfdktlpzl |
Sinopharm Is the Largest Drugs and Medical Devices Distributor in China
Business Strategy and Outlook
Unlike its two main, yet smaller, competitors Sinopharm is a pure-play medical distributor that does not have a sizable portion of revenue from the manufacturing business. As the largest medical distributor, Sinopharm has been growing at a 10-year compound annual growth rate, or CAGR, of 10.7%, with both industry expansion and industry consolidation. It aims to further increase distribution market share by deepening its network coverage and focusing on industry policies.